McKesson’s Horizon Cardiology is a complete cardiovascular information solution for cath, hemodynamic monitoring, echocardiography, vascular ultrasound and nuclear cardiology. It meets the full spectrum of needs for healthcare organizations with diagnostic digital image management, archiving, procedure reporting and workflow management.

The company introduced version 11.2 during the ACC, which features total Web accessibility and many enhanced features.

PressureWire Certus from RADI represents a paradigm shift in pressure guidewire design with handling characteristics comparable to those of any other high performance guidewire on the market. This means that guiding interventions using FFR is no longer a compromise. PressureWire Certus is a smooth tracking high-performance guidewire with these features:

Cardiac Science Corp.’s Pyramis ECG Data Management System centralizes diagnostic, hospital ECG data to provide instant electronic access to this information at any time or from any location. By automating and streamlining the storage, editing, retrieval and sharing of patient cardiology data including resting ECGs, stress tests, Holter tests, and 12-lead ECGs from bedside monitors, Pyramis helps increase workplace productivity and efficiency within hospitals and physician offices to provide enhanced patient care.

Two-year results presented at ACC from the Medtronic ENDEAVOR III trial confirm the positive clinical profile of the Endeavor drug-eluting coronary stent. Nearly 1,300 Endeavor patients have had at least two years of follow-up, none of whom have developed late stent thrombosis based on independent, pre-specified clinical trial protocol definitions for thrombosis.

Boston Scientific announced it will begin a new Plavix Compliance program aimed at helping patients with drug eluting stents stick with the full duration of their prescription for the dual anti-platelet inhibitors. Plavix has been identified by physicians and the FDA as a leading factor in preventing late stent thrombosis. Ninety-five percent of patients with insurance or Medicare receive full coverage for their Plavix prescriptions.

Cordis' Regatta Steerable Guide wire has a unique micro-ridge design and enhanced Torque Response at the tip. Micro-ridge tapers from the round central core into the flat portion and minimizes twisting in the flat region, therefore enhancing torque control. A gradual transition of the ridge minimizes prolapse.

Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were safely transformed from advanced heart failure to recovery, during ACC 2007.

Results of the COURAGE trial are unlikely to alter the approach that interventional cardiologists take in treating most patients with chronic stable angina, say leaders from the Society for Cardiovascular Angiography and Interventions (SCAI).

March 29, 2007 — Results of the COURAGE trial, presented today at the American College of Cardiology Annual Scientific Session, are unlikely to alter the approach that interventional cardiologists take in treating most patients with chronic stable angina, say leaders from the Society for Cardiovascular Angiography and Interventions (SCAI), the leading professional society for interventional cardiologists in the United States.

March 29, 2007 — Data released from the bridge-to-transplantation (BTT) arm of the HeartMate II Pivotal trial demonstrate that the device provides effective mechanical circulatory support as a bridge to transplantation for heart failure patients, and that these patients experience a lower number of adverse events and an improved quality of life while being supported by the device.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now